Apixaban Price Trend and Indexes Database 2025: Track Real-Time Pricing
In Q2 2025, Apixaban Price Trend in the USA rose to 44,617 USD/MT by June.
North America Apixaban Prices Movement Q2:
Apixaban Prices in USA:
In Q2 2025, Apixaban Price Trend in the USA rose to 44,617 USD/MT by June. The steady increase was driven by consistent demand for cardiovascular treatments, rising API production costs, and regulatory expenses. Stable supply chains and healthcare use supported firm pricing, while generics helped moderate sharp fluctuations throughout the quarter.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample
Note: The analysis can be tailored to align with the customer's specific needs.
APAC Apixaban Prices Movement Q2:
Apixaban Prices in China:
In Q2 2025, apixaban prices in China rose to 24,295 USD/MT by June. Growth was driven by strong demand for cardiovascular treatments and limited competition among key domestic producers. Stable supply and steady API procurement supported prices, while rising fermentation input costs added mild upward pressure to the overall market trend.
Apixaban Prices in India:
In Q2 2025, apixaban prices in India reached 30,369 USD/MT by June. Prices remained moderately firm, driven by steady demand from hospitals and specialty clinics. Local and Chinese API sourcing ensured stable supply, while currency fluctuations and higher formulation costs added slight upward pressure, reflecting a balanced demand-supply dynamic in the market.
Apixaban Prices in Korea:
In Q2 2025, apixaban prices in Korea reached 43,946 USD/MT by June. Prices remained stable to slightly firm, supported by steady demand and reliable supply chains. Modest pressure from early generic entries was offset by imported API reliance and expanded therapeutic approvals, maintaining a balanced, resilient pricing trend across the quarter.
Regional Analysis: The price analysis can be extended to provide detailed Apixaban price information for the following list of countries.
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.
Europe Apixaban Prices Movement Q2:
Apixaban Prices in Germany:
In Q2 2025, apixaban prices in Germany reached 55,269 USD/MT by June. Prices remained firm due to stable demand, tight patent-related supply controls, and delays in generic competition. Fermentation-based API production costs and steady procurement across hospitals and pharmacies contributed to price stability, maintaining overall resilience in the pharmaceutical market.
Factors Affecting Apixaban Prices:
Factors affecting Apixaban prices include raw material availability, manufacturing costs, regulatory policies, and demand from the pharmaceutical industry. Additionally, global supply chain disruptions and geopolitical tensions can influence price fluctuations by impacting production and distribution efficiency.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=22910&flag=C
Key Coverage:
- Market Analysis
- Market Breakup by Region
- Demand Supply Analysis by Type
- Demand Supply Analysis by Application
- Demand Supply Analysis of Raw Materials
- Price Analysis
- Spot Prices by Major Ports
- Price Breakup
- Price Trends by Region
- Factors influencing the Price Trends
- Market Drivers, Restraints, and Opportunities
- Competitive Landscape
- Recent Developments
- Global Event Analysis
How IMARC Pricing Database Can Help
The latest IMARC Group study, “Apixaban Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition,” presents a detailed analysis of Apixaban price trend, offering key insights into global Apixaban market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.
The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Apixaban demand, illustrating how consumer behaviour and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.
About Us:
IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC’s data-driven approach helps businesses navigate complex markets with precision and confidence.
IMARC Group provides professional chemical price analysis services to enable businesses to leverage their pricing and maximize profitability. Our thorough research examines market trends, competitor prices, customer willingness-to-pay, and costs, making data-driven decisions possible. By establishing pricing opportunities and cost-saving initiatives, we enable organizations to remain competitive and maximize market potential. Whether it's creating dynamic pricing strategies, performing cost benchmarking, or analysing pricing effects, our customized solutions enable companies to realize sustainable growth.
Contact us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No: (D) +91 120 433 0800 United States: +1-631-791-1145